%0 Generic
%A Besse, B.
%A Garcia Campelo, M. R.
%A Cobo Dols, M. A.
%A Quoix, E.
%A Madroszyk, A.
%A Felip, E.
%A Cappuzzo, F.
%A Denis, F.
%A Hilgers, W.
%A Romano, G.
%A Debieuvre, D.
%A Baldini, E.
%A Galetta, D.
%A Viteri, S.
%A Phan, M.
%A Schuette, W.
%A Zer, A.
%A Costantini, D.
%A Dziadziuszko, R.
%A Giaccone, G.
%T Activity of OSE-2101 in HLA-A2+non-small cell lung cancer (NSCLC) patients after failure to immune checkpoint inhibitors (IO): Final results of phase III Atalante-1 randomised trial
%D 2021
%@ 0923-7534
%U https://hdl.handle.net/10668/26997
%~